“It’s important to acknowledge the size of the issue and enormity of the challenge. Approximately 880,000 Australians are now living with a severe and complex mental illness,” said Dirk Otto, the general manager of Boehringer Ingelheim Australia
-
Latest News
New report unveils hidden cost of Alzheimer’s disease, with cases to double by 2050
Eli Lilly general manager Tori Brown said, “The report highlights a once in a generation opportunity to act on Alzheimer’s disease. It is good for patients, good for families and carers, good for health and aged care systems, and good for the economy."
-
Latest News Bondi Junction response must include increased funding and support for severe mental illness October 11, 2024
-
Latest News Pharmac announces expanded access to three cancer medicines October 11, 2024New Zealand's Pharmac has announced that from 1 November, it will expand access to Merck's ERBITUX (cetuximab) for bowel cancer, bendamustine for blood cancer, and pemetrexed.
-
Latest News Novartis-led partnership says heart health shouldn't be dependent on where you live October 11, 2024A recent heart screening program delivered by Shane Warne Legacy in partnership with Novartis, SiSu Health, and Wesfarmers has highlighted the critical role of accessible heart screening programs in improving health outcomes for those living in rural and regional areas of Australia.
-
Latest News Amplia Therapeutics CEO shares Prime Minister's Prize for Innovation October 10, 2024The Australian researchers and industry leaders were recognised for discovering a GSK-commercialised drug that started its development at Melbourne-based company Cytopia.
-
Australian Biotech TGA approves new indication for Telix’s Illuccix to include patient selection for PSMA-targeted therapy October 9, 2024Telix has announced that the TGA has approved the use of Illuccix to select patients for PSMA-targeted radionuclide therapy.
-
Latest News Healthy Bones Australia calls for greater Government commitment to bone health October 9, 2024Healthy Bones Australia is teaming up with an Olympian, doctors, politicians, and patients today to launch findings from a national burden of disease report.
-
Latest News Anyone wanting to know how this might work, look to New Zealand's Pharmac October 9, 2024Anyone wanting to understand how the proposed streamlined process for cost-minimised therapies could walk need only look to New Zealand.
-
Latest News Wesfarmers Health releases most comprehensive real-time dataset on cardiometabolic health October 9, 2024The inaugural 'Wesfarmers Health: Australia's Health Index' reveals that the country's health debt remains significant following the COVID-19 pandemic.
-
Latest News Peak bodies align in consensus statement on juvenile arthritis October 9, 2024In the leadup to World Arthritis Day, 11 health and allied peak bodies have aligned in a broad-based push to reduce critical delays in diagnosing the painful childhood illness Juvenile Arthritis, signing a consensus statement to be released at a National Stakeholder Forum in Parliament House today.
-
Latest News The consistent failure to speak out is degrading this critical public health program October 8, 2024Is it a case of 'The Emperor's New Clothes'? Does the 19th-century folktale about the foolishness of failing to speak up for the truth and what is right provide a valuable lesson?
-
Latest News New report reveals significant return from investment in adult vaccination October 8, 2024A new report commissioned by GSK has revealed that increasing investment in adult immunisation could deliver $1.1 billion in benefits every year.
-
Latest News Mark Butler confirms Norgine's creation of DFMO access program October 7, 2024“No child and family suffering through a high-risk neuroblastoma diagnosis will have to worry about receiving the world’s best treatment," said Health Minister Mark Butler.
-
Latest News CSL welcomes new treatment for high-risk cardiovascular disease to the PBS October 7, 2024CSL Seqirus has welcomed the recent PBS listing of VAZKEPA (icosapent ethyl) for statin-treated patients with elevated triglycerides and at high risk of heart attack and stroke.
-
Latest News The significant driver of growth is the dramatic shift to free PBS prescriptions October 3, 2024It appears that PBS spending is in a growth phase. New listings could be a contributing factor, but the real driver is a 22 million increase in prescriptions dispensed at no cost to patients.
-
Podcast The 'Dispatched' Week in Review Podcast - 4 October October 3, 2024A significant structural change in the PBS, which the Government attempted to blunt with 60-day dispensed quantities, is arguably the main growth driver in spending on the program. We discuss the change, which along with others, represents a major reversal in a decades-long approach to medicines access.
-
Latest News Women’s health collaboration calls for MBS reform to improve access to contraception October 3, 2024Australian women want more accurate information about their contraceptive choices, with 70 per cent believing they have insufficient education on contraception.
-
Latest News Rare disease company Sobi appoints new general manager for Australia and New Zealand October 3, 2024Rare disease company Swedish Orphan Biovitrum, Sobi, has announced the appointment of Chloé Pérot as its general manager for Australia and New Zealand.
-
Latest News Otsuka celebrates its tenth anniversary in Australia October 4, 2024Otsuka Australia’s employees have marked the company’s 10th anniversary in Australia with celebrations hosted by local managing director Soonhee Park and attended by senior executives from Japan.
-
Latest News When it comes to next steps on the HTA review, it's under consideration October 3, 2024Health Minister Mark Butler and the Pharmaceutical Benefits Advisory Committee are currently 'considering' what next on the health technology assessment review.
Australian Biotech
-
Amplia Therapeutics CEO shares Prime Minister's Prize for Innovation
October 10, 2024 -
TGA approves new indication for Telix’s Illuccix to include patient selection for PSMA-targeted therapy
October 9, 2024 -
UQ spider venom heart drug moves into clinical trials
October 7, 2024 -
Chimeric says cancer patient achieves complete response in CHM CORE-NK trial
October 7, 2024 -
Cyclopharm signs agreement makes major progress with US veterans and defence administrations
October 6, 2024
Other Health
-
Medibank expands four-day work week trial to 500 employees
October 9, 2024 -
Artrya submits application for Salix to the US FDA
September 30, 2024 -
'Australia’s child vaccination rates are world-leading. Our adult rates are not.'
August 19, 2024 -
HCF Research Foundation hosts roundtable to advance short stay joint replacements
July 22, 2024 -
Bupa Ventures to invest $20m to accelerate healthcare innovations
February 12, 2024
Latest Video
New Stories
-
Pharmac announces expanded access to three cancer medicines
October 11, 2024 - - Latest News -
Novartis-led partnership says heart health shouldn't be dependent on where you live
October 11, 2024 - - Latest News -
Bondi Junction response must include increased funding and support for severe mental illness
October 11, 2024 - - Latest News -
New report unveils hidden cost of Alzheimer’s disease, with cases to double by 2050
October 10, 2024 - - Latest News -
Amplia Therapeutics CEO shares Prime Minister's Prize for Innovation
October 10, 2024 - - Latest News -
Healthy Bones Australia calls for greater Government commitment to bone health
October 9, 2024 - - Latest News -
TGA approves new indication for Telix’s Illuccix to include patient selection for PSMA-targeted therapy
October 9, 2024 - - Australian Biotech